N- (2- (4- phenoxybenzyl)benzimidazol- 5- yl)methanesulfonamide
inhibits GluN1 and GluN2B receptors; structure in first source
Also Known As:
XK2 compound
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results